Eva Van Braeckel

10.0k total citations · 1 hit paper
63 papers, 1.2k citations indexed

About

Eva Van Braeckel is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Eva Van Braeckel has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 21 papers in Infectious Diseases and 20 papers in Epidemiology. Recurrent topics in Eva Van Braeckel's work include Cystic Fibrosis Research Advances (20 papers), Antifungal resistance and susceptibility (9 papers) and Mycobacterium research and diagnosis (7 papers). Eva Van Braeckel is often cited by papers focused on Cystic Fibrosis Research Advances (20 papers), Antifungal resistance and susceptibility (9 papers) and Mycobacterium research and diagnosis (7 papers). Eva Van Braeckel collaborates with scholars based in Belgium, Netherlands and United Kingdom. Eva Van Braeckel's co-authors include Bart N. Lambrecht, Pieter Depuydt, Eric Derom, Sebastiaan Dhont, Geert Leroux‐Roels, Cornelus C. Hermsen, Lander Foquet, Geert‐Jan van Gemert, Philip Meuleman and Robert W. Sauerwein and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Eva Van Braeckel

59 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The pathophysiology of ‘happy’ hypoxemia in COVID-19

2020 334 citations Eva Van Braeckel, Pieter Depuydt et al. Respiratory Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Van Braeckel Belgium	16	385	366	246	189	162	63	1.2k
Irina Chis Ster United Kingdom	21	368 1.0×	152 0.4×	280 1.1×	218 1.2×	44 0.3×	67	1.6k
Wentao Ni China	21	709 1.8×	179 0.5×	355 1.4×	338 1.8×	76 0.5×	47	2.0k
Miriam Stegemann Germany	19	691 1.8×	88 0.2×	279 1.1×	204 1.1×	199 1.2×	61	1.4k
Emmanuel Faure France	18	338 0.9×	126 0.3×	230 0.9×	442 2.3×	168 1.0×	51	1.4k
Yasemin Özsürekçi Türkiye	20	396 1.0×	193 0.5×	418 1.7×	166 0.9×	38 0.2×	135	1.3k
Yunxiao Shang China	20	672 1.7×	149 0.4×	360 1.5×	316 1.7×	81 0.5×	62	1.4k
Julie Delaloye Switzerland	11	467 1.2×	106 0.3×	647 2.6×	253 1.3×	323 2.0×	22	1.5k
Jaap ten Oever Netherlands	23	586 1.5×	91 0.2×	579 2.4×	205 1.1×	218 1.3×	89	1.8k
Sun Young Cho South Korea	25	872 2.3×	135 0.4×	445 1.8×	332 1.8×	48 0.3×	145	2.0k
Danielle Ahn United States	17	241 0.6×	158 0.4×	172 0.7×	409 2.2×	265 1.6×	22	1.1k

Countries citing papers authored by Eva Van Braeckel

Since Specialization

Citations

This map shows the geographic impact of Eva Van Braeckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Van Braeckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Van Braeckel more than expected).

Fields of papers citing papers by Eva Van Braeckel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Van Braeckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Van Braeckel. The network helps show where Eva Van Braeckel may publish in the future.

Co-authorship network of co-authors of Eva Van Braeckel

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Van Braeckel. A scholar is included among the top collaborators of Eva Van Braeckel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Van Braeckel. Eva Van Braeckel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salhi, Bihiyga, Cédric Bosteels, Eric Derom, et al.. (2025). Physical Activity and Physical Function One Year After Hospital Discharge for COVID-19. Journal of Clinical Medicine. 14(17). 6206–6206.

Hellemons, Merel E., Eva Van Braeckel, C. Tji Gan, et al.. (2025). Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study. JHLT Open. 7. 100210–100210.

Moors, Ine, Tessa Kerre, Yannick Vande Weygaerde, et al.. (2024). Baseline chest computed tomography for diagnosis of invasive aspergillosis in patients with acute myeloid leukaemia treated with intensive chemotherapy: A retrospective single‐centre cohort study. Mycoses. 67(3). e13715–e13715. 1 indexed citations

Taylor, Steven, Alison Dicker, Marie Joossens, et al.. (2024). Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro. Respiratory Research. 25(1). 368–368. 1 indexed citations

Aliberti, Stefano, Francesco Blasi, Pierre‐Régis Burgel, et al.. (2024). Mycobacterium aviumcomplex pulmonary disease patients with limited treatment options. ERJ Open Research. 10(1). 610–2023. 2 indexed citations

Grassi, Lucia, Kyle L. Asfahl, Andrea Saß, et al.. (2024). Antibiofilm activity of Prevotella species from the cystic fibrosis lung microbiota against Pseudomonas aeruginosa. Biofilm. 7. 100206–100206.

Salzer, Helmut J.F., Maja Reimann, Jesper Rømhild Davidsen, et al.. (2023). Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard. Clinical Microbiology and Infection. 29(12). 1605.e1–1605.e4. 4 indexed citations

Declercq, Dimitri, et al.. (2023). Effect of 18 months elexacaftor-tezacaftor-ivacaftor on body mass index and glycemic control in adults with cystic fibrosis. Clinical Nutrition ESPEN. 58. 73–78. 7 indexed citations

Declercq, Dimitri, Sophie Marchand, Eva Van Braeckel, et al.. (2022). Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosis. Journal of Cystic Fibrosis. 22(1). 59–65. 3 indexed citations

10.

Sprute, Rosanne, Eva Van Braeckel, Holger Flick, et al.. (2022). EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis. Journal of Antimicrobial Chemotherapy. 78(1). 225–231. 16 indexed citations

11.

Davidsen, Jesper Rømhild, et al.. (2022). Prevalence of Chronic Pulmonary Aspergillosis in Patients Suspected of Chest Malignancy. Journal of Fungi. 8(3). 297–297. 6 indexed citations

12.

Piers, Ruth, Eva Van Braeckel, Dominique Benoît, & Nele Van Den Noortgate. (2021). Early resuscitation orders in hospitalized oldest-old with COVID-19: A multicenter cohort study. Palliative Medicine. 35(7). 1288–1294. 6 indexed citations

13.

Declercq, Dimitri, Eva Van Braeckel, Sophie Marchand, Sabine Van daele, & Stéphanie Van Biervliet. (2020). Sodium Status and Replacement in Children and Adults Living with Cystic Fibrosis: A Narrative Review. Journal of the Academy of Nutrition and Dietetics. 120(9). 1517–1529. 14 indexed citations

14.

Weygaerde, Yannick Vande, et al.. (2020). Haemoptysis as the first presentation of COVID-19: a case report. BMC Pulmonary Medicine. 20(1). 275–275. 6 indexed citations

15.

Heijerman, Harry, D.G. Downey, Marcus Mall, et al.. (2019). Phase 3 efficacy and safety of the ELX/TEZ/IVA triple combination in people with CF homozygous for the F508DEL mutation. Ghent University Academic Bibliography (Ghent University). 2 indexed citations

16.

Weygaerde, Yannick Vande, Peter Bomans, Jerina Boelens, et al.. (2019). Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis. BMC Infectious Diseases. 19(1). 1061–1061. 35 indexed citations

17.

Minić, Predrag, Stijn Verhulst, Eva Van Braeckel, et al.. (2018). GLPG2222 in CF subjects homozygous for F508DEL : results from a phase II study (FLAMINGO). Ghent University Academic Bibliography (Ghent University). 1 indexed citations

18.

Verhulst, Stijn, Eva Van Braeckel, Patrick A. Flume, et al.. (2018). EPS3.05 GLPG2222 in subjects with cystic fibrosis homozygous for F508del: results from a phase II study (FLAMINGO). Journal of Cystic Fibrosis. 17. S42–S42. 2 indexed citations

19.

Declercq, Dimitri, Sophie Marchand, Eva Van Braeckel, et al.. (2018). The nutritional status in CF: Being certain about the uncertainties. Clinical Nutrition ESPEN. 29. 15–21. 8 indexed citations

20.

Vanhoecke, Barbara, Eva Van Braeckel, Arne Heyerick, et al.. (2005). A safety study of oral tangeretin and xanthohumol administration to laboratory mice.. Ghent University Academic Bibliography (Ghent University). 19(1). 103–7. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact